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The Relationships Among Pain, Dyspnea, Constipation and Quality of Life in Lung
Cancer Patients Enrolled in a Hospice Program
Lisa A. Laches
ABSTRACT
There is evidence of a relationship between pain and associated symptoms,
specifically constipation and dyspnea, and quality of life. Literature supports that endstage lung cancer patients suffer more symptoms than those with other types of cancers,
and the course of treatment is primarily palliative, as many of these diagnosed patients
cannot be cured. The purpose of this secondary analysis of data was to evaluate the
relationships between pain and other common symptoms in end stage lung cancer patients
in hospice care, and the relationships among pain, dyspnea, constipation and quality of
life. The study sample included fifty lung cancer patients admitted to a hospice program,
reporting pain. A series of Pearson’s correlations were used to analyze relationships
between the variables pain intensity, pain distress, dyspnea intensity, dyspnea distress,
constipation intensity and the relationships of these variables with quality of life. The
results showed positive significant correlations between pain intensity and pain distress (r
= .44, p = .002), dyspnea intensity and dyspnea distress (r = .47, p = .001), and
constipation intensity and quality of life (r = -.57, p = .013). Pain and the relief of pain
have been studied extensively in cancer patients, yet little research has been done in the
way of side effects of opioid use, specifically constipation. This study reinforces to
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nursing the importance of a thorough assessment upon admission to hospice, and at each
subsequent nursing visit, which includes a bowel habit history, current medications in use,
potential risk for developing constipation and management of constipation once it is
present.
Hospice patients with lung cancer are reporting a decrease in quality of life
secondary to constipation. Prevention or rapid alleviation of this symptom will provide
comfort and allow the patient to focus on important end of life tasks.

vi

Chapter I
Introduction
Lung cancer is the leading cause of cancer death for both men and women, and
is the most common malignancy worldwide (Potter & Higginson, 2003). The American
Cancer Society (ACS) reports that for the year 2007 there will be about 213,380 new
cases of lung cancer in the United States: 114,760 among men and 98,620 among women.
About 160,390 people will die of this disease including 89,510 men and 70,380 women.
About six out of ten people with lung cancer die within one year of being diagnosed.
Between seven and eight out of ten will die within two years (ACS, 2007). The
healthcare industry serves a large number of lung cancer patients, in either the curative or
palliative phase of treatment. The ability to properly assess, treat and manage pain and
disease related symptoms is a crucial component to quality of life improvement.
Medical advances such as chemotherapy, radiation therapy and surgery have
provided better tumor response rates, but have demonstrated little effect in overall
survival (Knop, 2005). The fact that the majority of lung cancer patients present with
advanced stages of disease and receive palliative or hospice care despite curative
treatment options, demonstrates the importance of symptom relief (Potter et al., 2003;
Cooley, 2000).
Many patients newly diagnosed with lung cancer present with advanced disease,
and have more symptoms than patients who are newly diagnosed with other types of
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cancer (Gift, Jablonski, Stommel & Given, 2004). Uncontrolled pain and the multiple
symptoms associated with lung cancer complicate a terminal prognosis. It is distressing
for family members to conceptualize suffering and symptoms associated with pain can
prevent patients from enjoying acceptable levels of quality in the remaining months of life
(Lobchuk, Degner, Chateau & Hewitt, 2006; McMillan & Weitzner, 2000). Prevalence of
pain in end-stage lung cancer patients ranges from forty to ninety percent, and can be
caused by the cancer itself or as a result of the therapies used to treat or palliate the
disease process (Knop, 2005). Pain is one of the most feared symptoms of a lung cancer
diagnosis (Potter, Hami, Bryan & Quiqley, 2003). The notable predominance of
palliation versus cure of lung cancer disease demonstrates the need for symptom
management to be a priority (Potter et al., 2003; Tishelman, Degner, Rudman, Bertilsson,
Bond, & Broberger, et al., 2005).
Problem statement
While there has been a great deal of research investigating single signs and
symptoms, such as pain or dyspnea, there is little research regarding assessment and
management of concurrent symptoms associated with pain in end stage lung cancer.
Symptoms that occur concurrently with pain in lung cancer are often not recognized or
assessed. This may be due to barriers created by both the healthcare system and the
patients themselves (Paice, 2004). By identifying these symptoms, the provider can
thoroughly assess general health status, and plan a course of treatment. Concurrent
symptoms can have an adverse effect on patient outcomes and an overall decrease in
quality of life (Dodd, Miaskowski & Paul, 2001). Therefore, it is critical for a complete
assessment to incorporate all limitations and concerns. The purpose of this study was to
2

evaluate the relationships between pain and other common symptoms in end stage lung
cancer patients in hospice care, and the relationships between pain, dyspnea and
constipation on quality of life.
Research Objectives
The following objectives will guide the study:
1. To identify the incidence and intensity of pain and symptoms related to pain,
specifically, constipation and dyspnea, in a sample of hospice patients with end stage lung
cancer.
2. To examine the relationships between pain intensity and the following variables: pain
distress, and dyspnea distress in a sample of hospice patients with end stage lung cancer.
3. To examine the relationships between pain distress and the following variables: pain
intensity, dyspnea intensity and constipation intensity.
4. To examine the relationships between total quality of life scores and the following
variables: pain intensity, pain distress, dyspnea intensity, dyspnea distress, and
constipation intensity in a sample of hospice patients with end stage lung cancer.
Definition of Terms
For purposes of this study, the following terms are defined:
1. Pain is defined as nociceptive, by referring to somatic or visceral pain, or neuropathic,
relating to peripheral or central nerve damage. Approximately sixty percent of lung
cancer patients experience nociceptive pain, while thirty percent report neuropathic
pain (Wilkie, Huang, Reilly & Cain, 2001).
2. Dyspnea is one of the most common subjectively perceived symptoms of advanced
cancer, and is defined as an “uncomfortable sensation of breathing” (Manning &
3

Schwartzstein, 1995). There are multiple contributing factors to this subjective
sensation such as previous life experience, cultural background, and psychological
state, all which can increase or decrease the perception of dyspnea (Ripamonti &
Bruera, 1997).
3. Constipation is defined as a decreased frequency in the passage of formed stools, and
is further characterized by hard stools that are difficult to pass (McMillan, 2002).
4. Quality of life is defined as a multifaceted concept, comprised of various dimensions
that make life worth living (McMillan & Weitzner, 1998; Gralla & Thatcher, 2004).
The concept of quality of life is further defined as being both subjective (what the
patient is experiencing) and multidimensional (various aspects of personal well-being)
(McMillan et al., 1998).
Significance to Nursing
Much research has been done in regard to pain, resulting in the creation of a
large variety of pain assessment tools and the development of evidence-based practice
protocols, such as the World Health Organization (WHO) pain ladder (WHO, 2007).
Results of this study may shed light on the importance of a thorough nursing evaluation
of end stage lung cancer patients upon admission to hospice, which includes not only a
complete physical examination, but an assessment of pain including location, descriptors
or quality, intensity, frequency, aggravating factors and alleviating factors. An important
part of the pain evaluation is the identification of associated symptoms which have been
shown in the literature to be prevalent in this group, such as dyspnea, fatigue, nausea and
constipation.
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Chapter II
Review of the Literature
It is well known that lung cancer is the leading cause of cancer-related death
(ACS, 2007). This chapter presents the review of literature. First, the Theory of
Unpleasant Symptoms is described. Following the introduction of the conceptual
framework, qualitative and quantitative research is presented as reviews of pain, related
symptoms, and quality of life in end stage lung cancer patients.
Conceptual Framework
The Theory of Unpleasant Symptoms (TOUS) (Lenz, Pugh, Milligan, Gift, &
Suppe, 1997) was used as the conceptual framework for this study. The Theory of
Unpleasant Symptoms proposes that similar factors may influence how a number of
different symptoms are experienced. Therefore, it can be said that similar interventions
may be effective for more than one symptom. The Theory of Unpleasant Symptoms also
proposes that when multiple symptoms are present, the patient is likely to experience a
multiplicative rather than additive effect.
The Theory of Unpleasant Symptoms is composed of three units: the symptoms
that the patient is experiencing, the factors that influence the nature of the symptom
experience (antecedents), and the consequences of the symptom experience. Antecedents
can include physiological (unpleasant symptoms), psychological (reaction to illness) and
situational variables (social situations). It is noted that these units can be related and have
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a reciprocal effect. The strength of the relationships is dynamic (Lenz et al., 1997; Gift,
Jablonski, Stommel & Given, 2004).
According to the Theory of Unpleasant Symptoms, each symptom the patient
reports is a multidimensional experience, and can be conceptualized and measured
individually or in combination with other symptoms. While the Theory of Unpleasant
Symptoms recognizes that symptoms are different from each other, it establishes that
there are common dimensions seen across symptoms, such as intensity, timing, level of
distress and quality (Lenz et al., 1997). This study focuses on symptom intensity and its
psychological effect, distress.
Literature Review
Pain
When assessing any type of pain, it is important to determine underlying
etiologies and other symptoms that are likely to accompany the pain. Pain can increase
the perception of severity of other symptoms (such as dyspnea, fatigue and constipation).
It also communicates to the patient that there is some degree of disease progression
(Griffin, Nelson, Koch, Niell, Ackerman & Thompson et al., 2006).
A 2001 study by Wilkie, Huang, Reilly and Cain evaluated whether descriptors
from the McGill Pain Questionnaire (MPQ²) were congruent with lung cancer patients’
descriptions of neuropathic and nociceptive pain. The final sample group consisted of
one hundred twenty-three patients from three Western states who were English speaking,
diagnosed with lung cancer, had at least one episode of pain within one week prior to data
collection and were physically able to ambulate on their own for two minutes.
Instruments used in this study included the following: the Demographic Data Form
6

(DDF), used to document oncologic variables and demographics; the McGill Pain
Questionnaire was used to gather information from the patient regarding pain location,
intensity, depth, quality and pattern; and the Lung Cancer Etiology Tool (LCET), which
was developed for this study to tabulate data regarding eleven criteria defining
nociceptive pain sites, and fourteen criteria defining neuropathic pain sites. To further
elaborate on this tool, pain sites were considered nociceptive unless at least one
neuropathic element was documented. If nociceptive and neuropathic symptoms were
reported, then the site was categorized as mixed. Participants were asked to complete the
Demographic Data Form and McGill Pain Questionnaire forms. The McGill Pain
Questionnaire pain location and pattern was then reviewed in combination with the
Demographic Data Form, tumor location and cancer treatment data. The documented pain
sites (n = 457) were numbered in order of patient report and were considered in relation to
other pain sites when determining the etiology category as either nociceptive (n = 343) or
neuropathic (n = 114). Results of the study showed that out of the twenty-two
descriptors, four words were significant for describing nociceptive pain (heavy, stinging,
lacerating and suffocating), while eleven words were significant for describing
neuropathic pain (aching, tender, throbbing, pricking, pulling, tugging, punishing,
miserable, nagging, numb and penetrating). An interesting caveat to this population was
that they did not select terms frequently associated with neuropathic pain such as burning,
shooting, lancinating, tingling, itching, cold, flashing, blinding, torturing. Another
significant finding of this study was that the lung cancer participants reported neuropathic
pain fifty percent of the time, which is higher than neuropathic pain reported in other
groups (Wilkie et al., 2001).
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A 2004 phenomenological qualitative study by Coyle proposed to address
perceived barriers to pain management, misconceptions regarding opioid pain
medications, and fear generated by uncontrolled pain in advanced cancer patients. Seven
participants consented to a series of two or more in-depth interviews lasting from thirty to
sixty minutes, in the patients’ own setting, scheduled anywhere from one to sixty days
apart, depending on the patient’s needs. Results of the interviews revealed that
participants quickly learned that admitting to uncontrolled pain meant withholding of
treatments (which was perceived as ultimately losing time), changes in pain medication
regimen (which again lead to losing time due to side effects) and the realization that the
disease was progressing. Participants also revealed that when pain was uncontrolled their
level of hope and will to live was greatly diminished. Some even wished for a hastened
death. The fear generated by the pain was enough to invoke anxiety attacks in one of the
participants. Two of the interviewees recalled caring for family members who died in
pain, and could only imagine that they would suffer the same fate. Results of the study
showed that pain management was nonlinear throughout disease progression. While pain
relief was essential to the participants, the side effects were considered a heavy trade-off.
“What the disease was not able to destroy in their human spirit, the pain or uncontrolled
side effects of the opioids were able to accomplish” (Coyle, 2004, p. 308).
Other Symptoms
Many cancer patients report multiple symptoms that occur simultaneously
secondary to their disease or the treatment they are receiving (Cleeland, Mendoza, Wang,
Chou, Harle, & Morrissey, et al., 2000). Determining the predominant symptoms related
to pain in end stage lung cancer can establish a baseline standard of care, allowing
8

patients to receive adequate assessment and management of their pain, and thus maintain
an acceptable level of quality of life.
Chen and Tseng (2005) proposed to examine which cancer-related symptoms
cluster together, and to test the conceptual meanings of the revealed clusters. This was a
cross-sectional study involving one hundred fifty-one participants with various forms of
cancer in both inpatient (n = 128) and outpatient (n = 23) settings in northern Taiwan.
Study results were broken down into symptom occurrence, symptom severity, and
interference of symptoms with activities of living. The average number of symptoms
which occurred was 8.32 (SD = 3.72), with dry mouth being the most prevalent, fatigue
was next and anorexia was third. Analysis of symptom severity showed that the most
severe symptom was fatigue, followed by xerostomia and distress. Symptoms interfered
with work most, followed by enjoyment of life and general activity. Symptoms with the
highest correlation were grouped together into three main clusters: sickness cluster,
which encompassed pain, fatigue, sleep disturbance, anorexia and drowsiness; the
gastrointestinal cluster, which included nausea and vomiting; and the emotional cluster,
which involved distress and sadness. Validation of the symptom clusters revealed that
participants with stage III and IV cancer had significantly higher sickness cluster scores
than those with stage 0-II (p<0.001). Participants receiving chemotherapy at the time of
data collection had significantly higher scores on the gastrointestinal cluster than those
not receiving chemotherapy (p<0.001). Depressed participants (defined as a Hospital
Anxiety Depression Scale subscale score of >8) had significantly higher scores on the
emotional cluster than those who were not depressed (p<0.001) (Chen et al., 2005).
Many of the symptoms in end of life care are thought to follow a trajectory,
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implying that the symptoms become more severe as death approaches. There is value in
understanding the trajectory as medications providing relief of symptoms may require
adjustment as the disease progresses. Gift, Stommel, Jablonski and Given (2003) studied
whether a symptom cluster present in lung cancer patients at diagnosis remained present
three and six months later. This study was performed from a secondary analysis of one
hundred twelve patients with newly diagnosed lung cancer who were assessed at baseline,
three months and six months post diagnosis. The Theory of Unpleasant Symptoms served
as the conceptual framework for this study. The symptom cluster was pre-established
and consisted of fatigue, weakness, weight loss, appetite loss, nausea, vomiting and
altered taste.
Results of this study were reported using Cronbach α scores of .66 at three
months, and .75 at six months, which met reliability and showed that the symptom
clusters remained relatively the same over time. The answer to the second question of
changes over time in the mean number of symptoms and level of severity was shown as a
decline in number of symptoms reported (p<0.001) and a decrease in severity (p<0.002).
The third question, related to the relationship between the severity ratings for individual
symptoms at each time point, was found to have only moderate correlation along each
time point. The fourth question evaluated the ability to predict the number of symptom
clusters reported based on factors such as age, gender, the stage of lung cancer at
diagnosis, therapy received and number of co-morbid conditions. It was found that none
of the between-subjects factors (surgery or not, radiation or not, gender, age, etc.) except
staging of lung cancer at diagnosis showed significant correlation (p<0.001). Question
five evaluated whether symptom cluster severity was predictive of death. It was found
10

that symptom severity reported six months after diagnosis, age and stage of cancer at
diagnosis were predictors of death six to nineteen months after diagnosis (Gift, et al.,
2003).
Subgroups of lung cancer patients have been studied, as certain groups will
present with unique needs, and will tolerate treatment differently. Knowledge of specific
population needs can help health care professionals develop a plan of care that is realistic
and easy to follow. Gift et al. (2004) researched symptom clusters in elderly patients with
lung cancer. The purpose of their research was to identify the number, type, and cluster
of symptoms this group experienced. The sample was described as two hundred twenty
patients age sixty-five to eighty-nine years (mean = 72 years, SD = 5.02), newly
diagnosed with both early and late stage lung cancer. This study was a secondary
analysis of data collected as part of a larger study. The authors used the middle-range
Theory of Unpleasant Symptoms (TOUS) as the framework to guide their research.
Results of symptom occurrence showed that participants reported a mean of eleven
symptoms (SD = 4.95) with fatigue, nocturia, cough, pain, and difficulty breathing as the
top five. Mean symptom severity ranged from 1.31-2.33 on a 1-3 scale. Symptoms
reported to be most severe were lack of sexual interest, vomiting, trouble sleeping,
fatigue, pain and difficulty breathing. Symptoms perceived to cause the most limitation
in daily activities were fatigue, difficulty breathing, weakness, loss of coordination,
vomiting and pain. The relationship of these symptoms correlated with the ability to
perform daily activities (p<0.01). The seven symptoms found to form a cluster were
fatigue, nausea, weakness, appetite loss, weight loss, altered taste, and vomiting (Gift et
al., 2004).
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Among the many distressing symptoms that end-stage lung cancer patients may
experience, constipation is one of the least often evaluated (McMillan, 2002). Hospice
patients are at risk of developing constipation due to the use of opioids and other
medications used for symptom management, decreased food/fluid intake, decreased
activity levels and comorbidities such as stroke, diabetes, electrolyte imbalances and renal
failure (McMillan, 2004). Evaluation, prevention and treatment of constipation should be
part of the hospice patients’ daily care.
McMillan (2002) reported through secondary analysis of data collected from
seventy hospice patients, that sixty-three percent reported some degree of constipation,
with nineteen percent of these patients reporting severe constipation upon hospice
admission. Constipation was assessed using the Constipation Assessment Scale (CAS),
which is an eight-item three-point Likert-type scale that measures the presence and
intensity of constipation. Each item is rated by the patient as no problem, some problem,
or severe problem. Scores may range from 0 (no constipation) to 16 (worst possible
constipation). Constipation was evaluated two weeks after admission, and was found to
have increased to include sixty-eight percent of the patients enrolled in the study. This
increase is thought to be due to the fact that it takes about two weeks to completely
correct a constipation problem, and that opioids are adjusted frequently after hospice
admission, usually with an increase in dosage and/or frequency. When constipation was
evaluated four weeks after admission to hospice, it was found to have decreased to fifty
percent (McMillan).
Symptom Distress
Symptom intensity (the extent to which the pain is bad) differs from symptom
12

distress (the extent to which the pain is considered mentally anguishing) and each can be
approached in different fashions. Tishelman et al. (2005) discussed symptoms in patients
with lung cancer and sought to specifically distinguish distress from intensity of
symptoms by addressing four objectives. The first objective examined patterns of current
symptom intensity in relation to patterns of distress in a population of patients newly
diagnosed with inoperable lung cancer. The second objective evaluated the consistency
of symptom intensity and distress patterns across various time points in the study. The
third objective examined differences in patterns of intensity and distress in subgroups
based on certain demographic and disease-related variables. The last objective examined
the possible correlation of high symptom intensity to symptom distress. This was a
longitudinal quantitative study that took place in two different university hospitals that
specialize in the non-surgical treatment of lung cancer in Stockholm. Four hundred adults
were recruited with the only criteria being newly diagnosed inoperable lung cancer. Self
reported data was collected using an adapted version of the McCorkle and Young
Symptom Distress Scale (SDS) and the Thurstone Scale of Symptom Distress – Lung
Cancer (TSSD-LC) at baseline (T1), then two weeks later (T2), then one month after T1
(T3), then three months after T1 (T4), then six months after T1 (T5), then one year after
T1 (T6). Nine symptoms were assessed: fatigue, breathing, outlook, cough, appetite,
insomnia, pain, appearance and bowels. At T1, pain was ranked seventh in intensity, and
by T6, pain was ranked third. Interestingly, there was not a significant increase in
symptom distress. Fatigue and breathlessness actually caused more distress than pain.
Comments made in the discussion section of this report suggest that perhaps pain is
accepted as a part of cancer and to a degree may be expected, especially closer to death.
13

Breathlessness and fatigue were considered more distressing due to the association with
progression of disease (Tishelman et al., 2005).
Broberger, Tishelman and von Essen (2005) continued the research on the
original Tishelman et al. (2005) group of participants, to determine if there are
discrepancies or similarities in assessment of symptom occurrence and distress among
nurses and family caregivers. This portion of the study was broken up into two sections:
the Patient-Nurse Study (PN Study) and the Patient-Family Caregiver Study (PFC Study).
Inclusion criteria for the Patient-Nurse Study was as follows: participants should be able
to communicate in Swedish, have received radiation therapy for at least five consecutive
days, and data collection should coincide with one of the time points in the main project
(T2-T6). Thirty-three patient-nurse dyads met eligibility. Inclusion criteria for the
Patient-Family Caregiver Study was as follows: patients and family caregivers should be
able to communicate in Swedish, family caregivers should be over eighteen years of age
and have a close and stable relationship with the patient, and data collection should
coincide with one of the time points in the main project (T2-T6). A total of fifty-four
patient-family dyads were created. Data for this study was already collected from the
Symptom Distress Scale and Thurstone Scale of Symptom Distress – Lung Cancer Scale
from the main project. Results of the Patient-Nurse Study dyads revealed that the nurse
tended to assess the patients’ symptoms occurrence as greater than the patients did
(P<0.05). The nurses consistently rated symptom distress lower than what the patient
reported (P<0.05). Like the nurses, the family caregivers also rated the occurrence of
symptoms greater than the patients did, although there was closer agreement than the
nurses (P<0.01). Family caregivers did a better job than nurses when evaluating symptom
14

distress (P<0.01). This is thought to be due to the close nature of the relationship between
the patient and the caregiver versus the relationship between the patient and the nurse
(Broberger et al., 2005).
Cooley, Short and Moriarty (2003) examined symptom prevalence, distress and
changes over time in adults receiving treatment for lung cancer. The purpose of this
study was to describe which symptoms were most distressing, the prevalence of these
symptoms, how these symptoms change over time. This study was conducted from
secondary analysis of one hundred seventeen participants’ responses to the Symptom
Distress Scale, medical record review and interviews. Inclusion criteria involved a
histologic confirmation of lung cancer, participants had received treatment for cancer
(either surgery, chemotherapy, radiation, or combination of any these treatments), had no
other malignancy, were diagnosed within one hundred days of entering study and
completed all interviews at baseline, three months and six months.
When symptom distress was evaluated, all four treatment groups reported
fatigue as being the most prevalent distressing symptom at all three time points, with
frequency of pain second, insomnia third, appetite fourth and severity of pain fifth. The
second aim of this study, which focused on prevalence of distressing symptoms, broke
results down into the four treatment groups: surgery group (n = 45), radiation group
(n = 13), chemotherapy group (n = 8) and combined therapy (n = 51). In the surgery
group, pain, fatigue and insomnia were the three most distressing symptoms at baseline
and again three months later. Frequency of pain, fatigue and pain severity were the most
distressing symptoms six months. In the radiation group, fatigue, appetite and severity of
nausea were the top three distressing symptoms at baseline, fatigue, appetite and nausea
15

characterized the three month mark, and by six months this group listed fatigue,
frequency of pain and insomnia as the most distressing symptoms. In the chemotherapy
group, fatigue, appetite and frequency of pain were most distressing at the baseline
assessment and remained prevalent throughout the six months. In the combination group,
fatigue, frequency of pain, and insomnia were distressing at all three time points. The
third aim of this study was to evaluate how symptoms change over time. In general it was
noted that the treatment groups showed a decrease in symptom severity from baseline to
three months, with an increase at six months. The only consistent pattern of predictors
was symptom distress reported at baseline. Symptom distress at entry was able to predict
for nine of thirteen symptoms at three months, and seven of thirteen symptoms at six
months (Cooley et al., 2003).
A study by Degner and Sloan (1995) study looking at symptom distress in newly
diagnosed ambulatory cancer patients, and as a predictor of survival in lung cancer,
examined four hundred thirty-four cancer patients, eighty-two of whom had lung cancer,
in two different oncology clinics in Canada. The purpose of the study was to report levels
of symptom distress and to describe factors associated with this distress over a six month
period of time. Data collecting tools included participant completion of the Symptom
Distress Scale, direct interview, and medical chart review. Patients eighteen years of age
or older with a diagnosis of cancer within six months were approached.
Results showed that the level of symptom distress in this group was very low,
with most participants rating their symptom distress as one or two on a five point scale.
Fatigue, insomnia and pain were the most problematic symptoms reported. Women
reported more distress than men (p = 0.041) and patients with advanced disease at time of
16

diagnosis had more distress than those with early disease (p = 0.0001). Level of distress
was noted to depend on disease site, with lung cancer patients reporting the most distress.
Survival analysis of the lung cancer patients demonstrated that symptom distress scores
had a direct relation to survival. Stage of disease was seen as a covariate (Degner et al.,
1995).
Oi-Ling, Man-Wah and Kam-Hung (2005) published a study evaluating
symptom distress as rated by advanced cancer patients compared to the ratings of
caregivers and physicians in the last week of life. This was a prospective study, which
included all inpatient hospice patients admitted to a hospice ward in a Hong Kong
hospital with a life expectancy of two weeks or less to live. The Symptom Distress Scale
was administered to the participant upon admission to the ward, then every seven days
until the patient died. The distress from each symptom was rated on a 0-5 scale, with
grade 0 = not at all distressed, grade 1 = a little bit distressed, grade 2 = somewhat
distressed, grade 3 = quite a bit distressed, and grade 4 = very much distressed. Only
thirty patients were able to complete the two questionnaires needed to be included in the
study, with nineteen of these thirty completing more than two questionnaires as they lived
longer than the predicted two weeks. Only the questionnaire set completed within the last
week of life was included for analysis. Caregivers and physicians also completed the
same questionnaires based on their observation of the patients’ symptom distress.
Results of this study reveal that the median age of the participants was sixtynine years of age, gender ratio was equal men to women, entire sample was ethnic
Chinese, and lung cancer was the most common primary tumor, with gastrointestinal
cancers listed second. Of the thirteen symptoms listed on the Symptom Distress Scale,
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nine symptoms (of any distress grade) were most commonly reported to cause patient
distress: fatigue (100%) with a distress median score of 3, cachexia (93%) with a distress
median score of 3, anorexia (93%) with a distress median score of 3, dyspnea (70%) with
a distress median score of 1, dry mouth (60%) with a distress median score of 3, cough
(60%) with a distress median score of 1, pain (57%) with a distress median score of 1,
insomnia (47%) with a distress median score of 1, and constipation (47%) with a distress
median score of 1. The four most distressing symptoms rated by participants were
fatigue, cachexia, anorexia, and dry mouth, all with a distress median score of 3. Fatigue,
cachexia and anorexia were shown to cause the most frequent distress and were rated the
most distressing of all symptoms. Caregivers rated fatigue, cachexia and anorexia as
most distressing, but didn’t rate the severity of the distress as high as the patients.
Statistically significant agreement between raters was only evident for the symptoms of
dyspnea, cough, dry mouth, constipation and insomnia (all with P value <0.005).
Physicians also rated fatigue, cachexia and anorexia as the most distressing symptoms,
but again didn’t rate the severity of distress as high as the patients. Symptoms that
evoked statistically significant agreement between patients and physicians were dyspnea,
pain, and cough (all with P value <0.005) (Oi-Ling et al., 2005).
Quality of Life
Sarna, Brown, Cooley, Williams, Chernecky, Padilla, et al. (2005) studied the
quality of life (QOL) of two hundred seventeen women with non-small cell lung cancer
and relationships with demographics, health status and meaning of illness (MOI). This
was a descriptive, cross-sectional study. Assessment tools included the Quality of Life
Scale-Patient Version (QOL-Patient) (Cronbach α of 0.71-0.91 for this study), the Short
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Form-36 (Cronbach α of 0.95 for this study), and the Center for Epidemiologic StudiesDepression Scale (CES-D) (Cronbach α of 0.87 for this study). Meaning of illness was
assessed using a set of eight cards, each with a statement describing illness as positive,
negative or other meaning. Participants were asked to select a card with a statement most
relevant to how they feel. The mean age of the participants was sixty-five years (SD =
12.00), and Caucasians had the largest representation at eighty-five percent. The majority
of the participants had at least one comorbid condition (sixty-seven percent), with the
most common being chronic obstructive pulmonary disease (COPD). Eighty-seven
percent of the women had a history of smoking, and while ninety-nine percent attempted
to quit smoking upon diagnosis, only fifty-seven percent were able to do so. Thirty-five
percent indicated that they were depressed according to the results of the Center for
Epidemiologic Studies-Depression Scale. Quality of life assessment found that depressed
mood, meaning of illness, and a younger age were consistently related to a lower global,
physical, psychological, social and spiritual quality of life (all p<0.0001) (Sarna et al.,
2005).
Symptom frequency and severity in patients with metastatic or locally recurrent
lung cancer (LRLC) was evaluated by Lutz, Norrell, Bertucio, Kachnic, Johnson and
Arthur, et al. (2001). This study was a cross-sectional analysis of sixty-nine community
lung cancer patients considering radiotherapy for palliation of their advanced lung cancer.
The Lung Cancer Symptom Severity (LCSS) scale, which evaluates physical and
functional symptoms’ impact on quality of life, was administered upon initial radiation
consultation. Symptoms were reported in order of frequency as follows: fatigue (eighty
percent), cough (seventy-seven percent), dyspnea (seventy-three percent), loss of appetite
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(sixty-five percent), pain (fifty-seven percent), and hemoptysis (seventeen percent).
Evaluation of symptom severity revealed that fatigue, pain, dyspnea, and loss of appetite
were the most frequently reported. Quality of life was reported to have diminished prior
to death, with an increase of symptom frequency reported in all six categories. The major
limitation to this study is that the symptoms (appetite, fatigue, cough, dyspnea,
hemoptysis and pain) were predetermined by the Lung Cancer Symptom Severity Scale.
If other symptoms are present, such as constipation, they are not evaluated by this tool
(Lutz et al., 2001).
A 2000 quality of life descriptive study by McMillan and Weitzner reviewed
previously collected data from a 1998 study to identify most and least problematic aspects
of end of life care in hospice patients and the relation to quality of life. The sample
consisted of two hundred thirty-one homecare hospice patients with cancer in southwest
Florida. The sample mean age was seventy-one years, fifty-two percent of participants
were Caucasian, and the most common cancers reported were lung (22%), colorectal
(14%), breast (12%), and prostate (10%). The instrument used to collect data was the
Hospice Quality of Life Index (HQLI) which is a twenty-eight item self report
questionnaire broken down into three sections: functional well-being, psychophysiologic
well-being and social/spiritual well-being. Results of this analysis showed that the
functional well-being subscale mean score was 35.1 (SD = 14.8) (possible range of 0-70),
which was the lowest of the three subscales. The symptom that participants reported as
problematic most frequently was fatigue. The psychophysiologic well-being subscale
mean score was 93.2 (SD = 21.8) (possible range 0-130). More than half of the patients
reported feeling sad on this subscale. Items rated as the least problematic included hope,
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pain relief, feeling angry and nausea. The highest item mean scores were noted in the
social/spiritual well-being subscale, with almost half of participants rating satisfaction
with their relationship with God (McMillan et al., 2000).
Summary
Pain in end stage lung cancer is multidimensional and should be treated in a
manner that targets as many symptoms as possible. Pain can be caused by tumor
involvement, diagnostic and/or therapeutic interventions and toxicities of treatment,
which can cause different types of pain to occur simultaneously, requiring different types
of treatment or combined therapies (McGuire, 2004). The literature review demonstrates
that pain is frequently accompanied by other symptoms such as dyspnea, fatigue,
constipation and loss of appetite, which can increase symptom distress and decrease
quality of life.
Oncology nursing has much to gain by studying pain and accompanying
symptoms in the end stage lung cancer population. This extremely symptomatic group
has demonstrated that they suffer higher degrees of frequency and severity of symptoms
than patients with other types of cancers, and that these symptoms increased in frequency
and severity as the end of life approaches. Palliation of these symptoms will improve
perceived quality of life, affording the patient more time to complete end of life tasks.

21

Chapter III
Methods
The literature review on end stage lung cancer patients supports the idea that
there is a relationship between pain, associated symptoms and quality of life. This
chapter discusses study design, sample, assessment tools used, procedures, and statistical
analysis.
Sample and Setting
The sample for this present study was drawn from a previously completed study
that included three hundred twenty-nine home care hospice patients from a large not-forprofit hospice agency, located in southwest Florida. Data was obtained from an original
study evaluating the use of the COPE Intervention for family caregivers. This
intervention was shown to improve symptom management in hospice homecare patients
(McMillan & Small, 2007).
Inclusion criteria
Identification of potentially eligible participants was identified by hospice staff.
Inclusion criteria for the study was as follows: participants had to be able to read, and
understand English; minimum age of eighteen years or older; participants had to have a
diagnosis of end stage lung cancer; participants must rate pain at a level of three or more
on a 0-10 pain scale; and achieve a minimum score of eight on the Short Portable Mental
Status Questionnaire (SPMSQ).
Exclusion criteria
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Participants with cognitive issues who scored below eight on the Short Portable
Mental Status Questionnaire were excluded. Patients who displayed a performance status
of less than 40 (as determined by the Karnofsky Performance Scale) suggesting that they
would not live for more than a few days, were also excluded from this study.
Instruments
Short Portable Mental Status Questionnaire
The Short Portable Mental Status Questionnaire (SPMSQ) is a simple ten item
test of remote memory, knowledge of current events, and mathematical ability (Pfeiffer,
1975) (Appendix A). It is administered by the interviewer and scored on the number of
errors an individual makes and measures levels of mental impairment. The SPMSQ was
used to screen patients for eligibility for the study. Subjects with SPMSQ scores below
eight were excluded.
Demographic Data Form
Standard demographic data was collected on patients to allow description of the
sample. Data included age, gender, education, marital status, occupation, cancer
diagnosis, length of time since diagnosis.
Karnofsky Performance Status Scale
The KPS is a measure of functional status developed by Karnofsky et al. (1949)
that is widely used in oncology settings to assess patient functioning. The KPS is scored
on a scale from 0 (dead) to 100 (normal functioning) (Appendix B). KPS scores were
used to determine patient eligibility for the study. Patients with scores lower than 40
were excluded.
Pain Numeric Rating Scale
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Pain intensity was assessed using an eleven point numeric rating scale (NRS)
with scores ranging from 0 to 10 (Appendix C). The patient was asked to respond
verbally with a number between 0 (no pain) and 10 (worst pain) to rate pain intensity at
that moment (McGuire, 1984; Stewart, 1977).
Dyspnea Intensity Scale
Among patients with severe dyspnea and the resulting fatigue, an 11-point
Dyspnea Graphic Rating Intensity (DGRIS) can be used to assess dyspnea intensity
(Appendix D). This scale is preferred due to ease of administration and accuracy
(Moody, Lowry, Yarandi, & Voss, 1997; Silvestri & Mahler, 1993). Test-retest reliability
has ranged from .89-.92 and concurrent validity with other measures is .88-.94 (Moody et
al., 1997).
The Constipation Assessment Scale
The Constipation Assessment Scale (CAS) (McMillan & Williams, 1989) is an
eight-item three-point Likert-type scale that measures the presence and intensity of
constipation. Each item is rated by the patient as no problem, some problem, or severe
problem. Scores may range from 0 (no constipation) to 16 (worst possible constipation).
Test-retest with brief delay provided strong evidence of reliability of this scale (r = .98).
Memorial Symptom Assessment Scale
The Memorial Symptom Assessment Scale (MSAS) (Portenoy et al., 1994) was
used to measure distress caused by symptoms other than the three target symptoms. The
Memorial Symptom Assessment Scale is a patient self-report scale that assesses a diverse
group of symptoms common to persons with cancer. Subscales provide data about
frequency, severity, and distress associated with these symptoms. Distress is measured on
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a 5 point summated rating scale with total scale scores that may range from 0 (no distress)
to 96 (very much distress). Validity was supported by high correlations with clinical
status and quality of life. Alpha reliabilities were high (.83-.88).
Hospice Quality of Life Index
The Hospice Quality of Life Index (HQLI) (McMillan & Weitnzer, 1998) is a
twenty-eight item tool that measures overall quality of life (Appendix E). This scale is
divided into three sections which measure psychophysiological well-being (physical
problems and psychological problems), functional well-being (ability to complete normal
activities of daily living, ability to concentrate and independence), and social/spiritual
well-being (spirituality, relationship with God, relationships with family and friends).
Items are reported on a zero to ten scale, with zero indicating the greatest impact on
quality of life, and two hundred eighty indicating no impact on quality of life (McMillan
et al., 1998). Factor analysis confirmed these subscales, and alpha coefficients ranged
from 0.84-0.86.
Procedures
The original study was approved by the hospice ethics committees, and the
University’s Institutional Review Board. Following study approval, hospice staff
members were hired and trained to perform data collection roles. Participants were
identified by hospice staff, as well as medical record review, as having a diagnosis of lung
cancer, and were reporting pain. Once approached, participants were educated regarding
the purpose of the study, commitment required, and inclusion criteria.

Upon agreement

to participate, the patients were screened with the Short Portable Mental Status
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Questionnaire (SPMSQ). If patients passed the SPMSQ, the symptom and quality of life
scales were administered.
Data Analysis
For this current study, the existing data set from the original Caregiver Study
was accessed via the Statistical Package for the Social Sciences (SPSS). Descriptive
statistics were used to analyze the demographic variables, including means, standard
deviations, percentages and frequencies. A series of Pearson correlations were used to
analyze the relationships between pain and other identified commonly occurring
symptoms, and whether these symptoms have a relationship with quality of life.
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Chapter IV
Results, Discussion and Conclusions
This chapter presents the findings of the study. Included in this chapter are the
study results, discussion of results, and conclusions.
Results
Demographic Data
The original study by McMillan and Small (2007) included hospice patients
with thirty-nine different cancer diagnoses. Lung cancer patients made up the largest
portion of this group (35%). The next largest group was colon cancer at 14%. The
sample for this secondary analysis consisted of fifty end-stage lung cancer patients rating
pain at a level of 3 or greater. Thirty-six were males (72%) and fourteen were females
(28%). This sample was composed primarily of Caucasians (90%), African Americans
(6%), and Hispanics (2%). The mean number of months since diagnosis was thirteen.
The mean educational level of the sample was approximately twelve years. Thirty-four
(68%) of the patients in the sample were married, ten (20%) were divorced, and five
(10%) were widowed. One person was never married (Table 1).
Incidence and Intensity of Pain, Constipation and Dyspnea
The first research objective evaluated the incidence and intensity of pain,
constipation and dyspnea. Data was derived from three measures, the CAS, NRS and the
DGRIS. The NRS, a self-report 0-10 pain scale, was used to evaluate pain intensity. The
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Table 1. Frequency and Percentage of Patients by Sex, Race, Marital Status and
Education (n = 50)
Demographic

frequency

percent

________________________________________________________________________
Sex
Male

36

72

Female

14

28

Caucasian

45

90

African American

3

6

Hispanic

2

4

Married

34

68

Divorced

10

20

Widowed

5

10

Never married

1

2

8 years or less

5

10

9 years

1

2

10 years

1

1

11 years

7

14

12 years or greater

36

72

Race

Marital status

Education

________________________________________________________________________
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mean pain intensity level reported was 4.7 (standard deviation = 1.5, n = 50). The CAS is
a 0-16 scale which measures the presence and severity of constipation. The mean for
constipation severity was 3.4 (standard deviation = 2.7, n = 50). The DGRIS is a 0-10
scale which measures dyspnea intensity. The dyspnea intensity mean for this group was
4.3 (standard deviation = 2.8, n = 50) (Table 2).
Relationships Among Variables
Each of the remaining three research objectives examined relationships among
the variables, pain intensity, pain distress, dyspnea intensity, dyspnea distress,
constipation intensity and quality of life. Because of missing data, some correlations
were calculated with less than fifty patients.
Pain intensity and pain distress. Part one of the second research objective
examined a relationship between pain intensity and pain distress. The study showed that
there was a significant positive correlation (p = .002) between pain intensity and pain
distress (Table 3).
Pain intensity and dyspnea distress. Part two of the second research objective
evaluated a possible relationship between pain intensity and dyspnea distress. No
significant correlation between pain intensity and dyspnea distress was found (Table 3).
Pain distress and dyspnea intensity. Part one of the third research objective
evaluated a possible relationship between pain distress and dyspnea intensity. No
significant correlation between pain distress and dyspnea intensity was found (Table 3).
Pain distress and constipation intensity. Part two of the third research objective
examined possible correlation between pain distress and constipation intensity. No
significant correlation between these two symptoms were identified (Table 3).
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Table 2. Ranges, Means and Standard Deviations (SD) for the NRS, CAS, DGRIS and
MSAS.

Variables

N

Possible
range

Actual
range

Mean

SD

________________________________________________________________________
Pain intensity

50

0-10

3-8

4.7

1.5

Constipation presence/
intensity

50

0-16

0-12

3.4

2.7

Dyspnea intensity

50

0-10

0-9

4.3

2.8

Pain distress

48

0-4

1-4

2.5

1.0

Dyspnea distress

44

0-4

0-4

2.3

1.3

________________________________________________________________________

Relationships with Quality of Life
Research objective four examined the variables pain intensity, pain distress,
dyspnea intensity, dyspnea distress, constipation intensity and their relationship with
quality of life.
Pain intensity and quality of life. The first part of this objective was to research
a possible relationship between pain intensity and quality of life. No significant
correlation was found between these two variables (Table 3).
Pain distress and quality of life. The second part of this research objective was
to examine the variables pain distress and quality of life. No significant correlation was
found (Table 3).
Dyspnea intensity and quality of life. The third part of the objective evaluated
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Table 3. Pearson Correlations Among Pain Intensity and Pain Distress Variables from
NRS, CAS, MSAS, and HQLI tools.
Dyspnea
Dyspnea
Constipation
Pain
Pain
Quality
Variables
distress
intensity
intensity
distress
intensity of life
________________________________________________________________________
Dyspnea
n=
44
16
distress
r=
.21
-.26
p=
.175
.332
Dyspnea
intensity

n = 44
r = .47
p = .001

Constipation
intensity

n = 44
r = .18
p = .208

Pain
distress

n = 43
r = -.015
p = .925

48
.11
.468
50
.10
.507
48
.21
.152

50
.23
.112

18
-.09
.709

50
.17
.241

18
-.57
.013
18
-.24
.346

Pain
intensity

n = 44
48
18
r = .13
.44
-.14
p= .399
.002
.578
________________________________________________________________________

pain intensity in relation to quality of life. The findings show that there is no significant
correlation between these two variables (Table 3).
Dyspnea distress and quality of life. The fourth part of the objective addressed
the two variables pain distress and quality of life. The findings show that there is not a
significant correlation between pain distress and quality of life.
Constipation intensity and quality of life. The last part of this research objective
evaluated the relationship between constipation intensity and quality of life, which were
found to be significantly correlated (p = .013) (Table 3).
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Discussion
This secondary analysis of previously collected data examined relationships
between pain, dyspnea and constipation, and the relationships of each of these symptoms
with total quality of life. Limitations of this study include the fact that it is not
generalizable to the non-hospice population, the sample was primarily Caucasian, and the
sample size was relatively small. Patients with lung cancer tend to present with
symptoms, and because of this, palliation is started almost immediately after diagnosis.
Palliation usually includes the use of opioid analgesics that are known to be constipating.
Patients receiving treatment for their cancer are also at risk for constipation as they may
have a decreased ability to ambulate secondary to dyspnea, and have decreased food and
fluid intake due to nausea from treatment. Thorough assessment of all hospice patients
upon admission and at every subsequent visit should include an evaluation of
constipation, initiation of preventative measures, and follow up of intervention.
Demographic Data
The sample consisted of fifty end-stage lung cancer patients admitted to a
hospice program who were reporting pain at a level of at least 3 on a 0-10 pain scale. The
majority of the sample was male (72%), which is consistent with ACS statistics, that
report that over half of all people diagnosed with lung cancer are male.
The overwhelming majority of study participants in this group were Caucausian.
While it is not uncommon to see this type of disparity in hospice care (Greiner, Perera
& Ahluwalia, 2003), it is one of the limitations of this study.
Incidence and Intensity of Pain, Constipation and Dyspnea
Pain incidence and intensity was derived from the Pain Numeric Rating Scale,
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which is a self-report 0-10 pain scale used to evaluate pain intensity. A requirement of
study participation was that the patient reported a pain level of at least 3. The mean pain
level reported was 4.7 (SD = 1.5, n = 50). This moderate pain rating suggests that newly
admitted hospice patients were experiencing some pain control, but pain was still a
problem. While the mean pain level is in the moderate range, some patients reported pain
intensity as great as 8. A review of research by Potter et al. (2004) reported that seventysix percent of patients recruited from palliative care settings for a pain study reported
pain. This might be a result of advanced disease including metastasis, which is usually
present in end stage disease.
Constipation presence and severity was measured using the CAS, which is a 016 rating scale. The mean constipation severity reported for this group of newly admitted
hospice patients was 3.4 (SD = 2.7, n = 50). This is a moderate rating on the CAS scale,
and determines presence of a problem. Some participants reported constipation intensity
as high as 12 on the scale. This finding is supported in the literature by McMillan (2002),
who found that the mean score for constipation in newly admitted hospice patients was
3.3 (SD = 3.4).
Dyspnea intensity was measured using the DGRIS, which is a 0-10 rating scale.
The dyspnea intensity mean for this group was 4.3 (SD = 2.8, n = 50). The highest
dyspnea intensity rating reported in this group was 9. This finding is also supported in the
literature by Moody and McMillan (2003) who reported that the mean dyspnea ratings
reported by a group of hospice patients was 4.5 (SD = 2.2).
Relationships Among Variables
Pain intensity and pain distress. The positive significant correlation between
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pain intensity and pain distress (r = .44, p = .002) might be expected. It has previously
been reported that eighty-five percent of patients experience pain in the end of life, with
fifty-six percent of these patients reporting that the pain is distressing (Edmonds, Karlsen,
Kahn & Addington-Hall, 2001). A later study by Broberger et al. (2005) did not support
a direct correlation between these two variables. Other symptoms were reported to be
more distressing than pain, specifically fatigue and breathlessness. Broberger and
colleagues (2005) concluded that lung cancer patients expect to have a certain degree of
pain, especially towards death.
Pain intensity and dyspnea distress. The finding of no significant correlation
between pain intensity and dyspnea distress (r = .13, p = .399) was unexpected. There is
much literature supporting the idea that these two variables co-exist, but no literature
supporting a significant relationship (Tischelman, Degner & Mueller, 2000; Higginson &
McCarthy, 1989).
Pain distress and dyspnea intensity. No significant correlation was found
between the two variables pain distress and dyspnea intensity (r = .11, p = .468).
Literature supports that these two variables frequently exist together in patients with lung
cancer (Higginson et al., 1989; Lutz et al., 2001), but there has been no evidence to
support a direct relationship.
Pain distress and constipation intensity. There was not a significant relationship
between pain distress and constipation intensity (r = .21, p = .152). This reasonable
finding may reflect constipation as a side effect of pain management. A patient reporting
a high level of distress caused by pain is probably not getting adequate treatment with
pain medications, and therefore would not be as likely to be constipated. In a study by
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McMillan (2002), constipation was a symptom reported most frequently by lung cancer
patients.
Relationships with Quality of Life
Pain intensity and quality of life. It was unexpected that pain intensity did not
have a relationship with quality of life (r = -.14, p= .578), which differs from the literature
that found a direct correlation (Wang, Cleeland, Mendoza, Engstrom, Liu & Xu, et al.,
1999). It is possible that the moderate mean pain level reported (4.7) was found to be less
of a problem as compared to constipation. If reported pain levels were higher, a stronger
correlation between pain and quality of life may have been observed. A lack of
correlation between these two variables may also be secondary to a restricted range
problem, as patients were excluded from this study if pain was rated less than 3 on the
0-10 pain numeric rating scale. Despite the fact that there was no correlation, it is an
important finding as it demonstrates the importance of a thorough pain assessment upon
admission to hospice.
Pain distress and quality of life. The finding of no significant correlation
between pain distress and quality of life (r = -.23, p = .346) is understandable for the same
reasons that pain intensity did not impact quality of life. Pain distress and pain intensity
were significantly correlated in this study group (r = .44, p = .002).
Dyspnea intensity and quality of life. The finding of no significant correlation
between dyspnea intensity and quality of life (r = -.09, p = .227) was unexpected. In this
study, this finding might be explained by the moderate mean dyspnea intensity level
(mean = 4.3, SD = 2.8) reported by this group. This may also be explained by early
referral to hospice, before symptoms are severe. There is literature which reports a
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significant increase in dyspnea at the end of life (Higginson et al., 1989), as well
as an impact on the quality of life (McMillan & Weitzner, 2000).
Dyspnea distress and quality of life. It is an unexpected finding that there was
no significant correlation between dyspnea distress and quality of life (r = -.25, p = .332)
for the same reasons discussed in the previous section. Dyspnea distress and dyspnea
intensity were significantly correlated in this study group (r = .46, p = .001).
Constipation intensity and quality of life. The two variables, constipation
intensity and quality of life, were found to have a positive significant correlation
(r = -.57, p = .013), and confirms results of previous studies (McMillan et al., 2000). The
prevalence of constipation in the hospice population indicates the need for improved
symptom assessment upon admission to hospice, teaching preventative measures, and
follow up of interventions during routine nursing visits to prevent or treat the problem on
a continuous basis.
Implications for Nursing
This study demonstrates the importance of addressing pain, dyspnea and
constipation in the lung cancer patient receiving end of life care. The significant
correlation found between constipation and quality of life warrants further investigation
of the effects of pain management on constipation. Education of hospice staff on the
assessment, prevention and management of constipation would greatly benefit this
subpopulation of hospice patients. Implementation of a constipation assessment protocol,
administered upon admission, and reevaluated upon each subsequent routine nursing visit,
would be beneficial for the patient, family and hospice nursing practice.
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Recommendations for Further Research
In order to improve generalizability of this research, a larger study sample could
be accessed which includes a more heterogeneous mix of ethnicities representative of
lung cancer statistics. The study could be replicated in other geographic regions. Distress
from constipation was not assessed in this study, and future studies might include that
important variable. Development of a constipation prevention protocol, which could be
implemented upon admission to a hospice program, is worthy of exploring.
Conclusions
The purpose of this secondary analysis of data was to evaluate pain intensity and
distress, dyspnea intensity and distress, and constipation intensity and the relationship of
these variables to quality of life. The study found significant relationships between pain
intensity and pain distress, and dyspnea intensity and dyspnea distress. Constipation was
the only variable found to be significantly correlated with quality of life in this
subpopulation. This is an important finding, as participants in this study rated pain and
dyspnea at moderate levels, but constipation was the only variable shown to have a
relationship with quality of life. Education of staff members regarding this important
aspect of assessment will ultimately benefit the patient, and perhaps improve their overall
quality of life.
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Appendix A
SHORT, PORTABLE MENTAL STATUS QUESTIONNAIRE
Eric Pfeiffer, M.D.
Instructions: Ask questions 1-10 in this list and record all answers. Ask question 4A only
if patient does not have a telephone. Record total number of errors based on ten questions.
+
1.

2.
3.
4.

1. What is the date today? ______________________________________
month
day
year
2. What day of the week is it? ___________________________________
3. What is the name of this place? ________________________________
4. What is your telephone number? _______________________________

4A.

4A. What is your street address? _________________________________
(Ask only if patient does not have a telephone)

5.

5. How old are you? ___________________________________________

6.

6. When were you born? ________________________________________

7.

7. Who is the president of the U.S. now? ___________________________

8.

8. Who was president just before him? _____________________________

9.

9. What was your mother’s maiden name? __________________________

10.

10. Subtract 3 from 20 and keep subtracting 3 from each new
number you get, all the way down. ________________________________
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Appendix B
KARNOFSKY PERFORMANCE STATUS SCALE
100

Normal; no complaints; no evidence of disease.

90

Able to carry on normal activity; minor signs or symptoms of disease.

80

Normal activity with effort; some signs or symptoms of disease.

70

Cares for self; unable to carry on normal activity or to do active work.

60

Requires occasional assistance, but able to care for most needs.

50

Requires considerable assistance and frequent medical care.

40

Disabled; requires special care and assistance.

30

Severely disabled; hospitalization indicated although death not imminent.

20

Very sick; hospitalization necessary; active supportive treatment necessary.

10

Moribund; fatal processes progressing rapidly.

0

Dead
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Appendix C
PAIN NUMERIC RATING SCALE
Directions: If zero is NO pain and 10 is the WORST POSSIBLE PAIN, where would
you place your pain right now?

0

1

2

3

4

5

No
Pain

6

7

8

9

10
Worst
Possible
Pain
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Appendix D
DYSNPNEA INTENSITY RATING SCALE
Directions: If zero is NO shortness of breath and 10 is the WORST POSSIBLE shortness
of breath, where would you place your shortness of breath right now?

0

1

2

3

4

5

No
Shortness
Of Breath

6

7

8

9

10
Worst
Possible
Shortness
of Breath
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Appendix E
HOSPICE QUALITY OF LIFE INDEX-REVISED
1998
The questions listed below will ask about how you are feeling at the moment and how
your illness has affected you. Please circle the number on the line under each of the
questions that best shows what is happening to you at the present time.

1) How tired do you feel?
extremely 0

1

2

3

4

5

6

7

8

9

10 not at all

2) How well do you sleep?
not at all 0

1

2

3

4

5

6

7

8

9

10 very well

3) How breathless do you feel?
extremely 0

1

2

3

4

5

6

7

8

9

10 not at all

4) How well do you eat?
poorly 0

1

2

3

4

5

6

7

8

9

10 very well

5) How constipated are you?
extremely 0

1

2

3

4

5

6

7

8

9

10 not at all

5

6

7

8

9

10 not at all

6) How nauseated/sick do you feel?
extremely 0

1

2

3

4

7) For Men: How masculine do you feel? For Women: How feminine do you feel?
not at all 0

1

2

3

4

5

6

49

7

8

9

10 extremely

Appendix E (Continued)
8) Do you have enough physical contact with those you care about? (Touching, holding
hands, hugging or other physical contact)
none 0

1

2

3

4

5

6

7

8

9

10 a great deal

9) How sad do you feel?
very sad 0

1

2

3

4

5

6

7

8

9

10 not at all

9

10 believe strongly

10) Do you believe that each day can still hold some good?
not at all 0

1

2

3

4

5

6

7

8

11) How worried do you feel about what is happening to you?
very worried 0

1

2

3

4

5

6

7

8

9

10 not at all

9

10 not at all

12) How worried do you feel about your family and friends?
very worried 0

1

2

3

4

5

6

7

8

13) How angry do you feel about what is happening to you?
very angry 0

1

2

3

4

5

6

7

8

9

10 not at all

4

5

6

7

8

9

10 not at all

14) How lonely do you feel?
very lonely 0

1

2

3

15) How satisfied do you feel with your ability to concentrate on things?
very
dissatisfied 0

1

2

3

4

5
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6

7

8

9

very
10 satisfied

Appendix E (Continued)

16) How meaningful is your life?
not at all
meaningful 0

1

2

3

4

5

6

7

8

9

very
10 meaningful

17) How much enjoyable activity do you have?
none 0

1

2

3

4

5

6

7

8

9

10 a great deal

18) How satisfied do you feel about the amount of usual daily activities you are able to
do?
(job, housework, chores, child care etc.)
very
dissatisfied 0

1

2

3

4

5

6

7

8

9

very
10 satisfied

9

very
10 satisfied

19) How satisfied are you with your level of independence?
very
dissatisfied 0

1

2

3

4

5

6

7

8

20) How satisfied are you with the support you receive from family and friends?
very
dissatisfied 0

1

2

3

4

5

6

7

8

9

very
10 satisfied

9

very
10 satisfied

21) How satisfied are you with your social life?
very
dissatisfied 0

1

2

3

4

5

6

7

8

22) How satisfied are you with the physical care that you are receiving?
very
dissatisfied 0

1

2

3

4

5
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6

7

8

9

very
10 satisfied

Appendix E (Continued)

23) How satisfied are you with the emotional support you get from your health care team?
very
dissatisfied 0

1

2

3

4

5

6

7

8

very
10 satisfied

9

24) How satisfied are you with your relationship with God (however you define that
relationship)?
very
dissatisfied 0

1

2

3

4

5

6

7

8

very
10 satisfied

9

25) How satisfied are you with the spiritual support you get from your health care team?
very
dissatisfied 0

1

2

3

4

5

6

7

8

very
10 satisfied

9

26) Do your surroundings help improve your sense of well-being?
not at all 0

1

2

3

4

5

6

7

8

9

10 very much

27) How much do you worry about your living expenses/finances?
1

a great deal 0

2

3

4

5

6

7

8

9

10 not at all

28) If you experience pain, how completely is it relieved?
no relief 0

1

2

3

4

5

6

7

8

9

10 complete relief

How bad is your pain when it is at its worst?
no pain 0

1

2

3

4

5

6
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7

8

9

10 worst possible

